SUPERNUS PHARMACEUTICALS, INC. Interest Paid, Discontinued Operations
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Interest Paid, Discontinued Operations of $9.04 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2012-11-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidDiscontinuedOperations · last filed 2012-11-02
- SUPERNUS PHARMACEUTICALS, INC. interest paid, discontinued operations for the quarter ending 2011-09-30 was $3.01M.
- SUPERNUS PHARMACEUTICALS, INC. interest paid, discontinued operations for the quarter ending 2011-06-30 was $3.00M.
- SUPERNUS PHARMACEUTICALS, INC. interest paid, discontinued operations for the quarter ending 2011-03-31 was $3.03M.
| Period end | Interest Paid, Discontinued Operations 3 month | Interest Paid, Discontinued Operations 6 month | Interest Paid, Discontinued Operations 9 month |
|---|---|---|---|
| 2011-09-30 | $3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $6.01M derived: sum of 2 quarters · filed 2012-11-02 | $9.04M 10-Q · filed 2012-11-02 |
| 2011-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $6.03M 10-Q · filed 2012-08-13 | |
| 2011-03-31 | $3.03M 10-Q · filed 2012-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |